The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

(MENAFN) Russia’s Gamaleya Research Institute, known for developing the Sputnik V COVID-19 vaccine, is close to gaining regulatory approval for a personalized mRNA cancer vaccine. According to ...

President Trump's $500 billion Stargate Initiative to build AI infrastructure faces blowback from his conspiracist supporters ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...

Oracle founder Larry Ellison said the Stargate project, a joint venture with OpenAI and Softbank, will help to fuel the ...

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative ...

Breast cancer cases in Americans under 45 years old dramatically increased after the introduction of mRNA COVID-19 vaccines, from approximately 26,000 in 2019-2022 to 297,000 in 2023, a nearly 1,000% ...

Modern medicine is helping clinicians tailor cancer treatments for individuals and Birmingham researchers are at the ...

The vaccine acts like a "wanted poster" unmasking cancer cells that are adept at hiding in the body, only to resurface later.